Supplementary Figure S2 . Anti-inflammatory Effects of Freshly-prepared and Stored NTG-NL. EC monolayers were treated with L-NIO ± NTG-NL (100 µg/ml) that were either (A) freshly synthesized or (B) stored at 4°C or 37°C for 24 hr prior to use. Quantification of adherent U937 cells (per mm 2 ) on EC monolayers (n = 10 fields of view) reveals significant inhibition in U937 cell-EC adhesion following treatment with NTG-NLs that were stored for 24 hr, indicating stable retention of NTG within the lipid core of nanoliposomes. ***, p<0.001; ns, no significance. (C) Pulmonary sheep arteries pretreated with the effective (anti-inflammatory) free NTG dose of 5 µM exhibit normal NTG dose-relaxation profile similar to untreated controls. In contrast, arteries pretreated with a 20-fold higher free NTG dose (100 µM) demonstrate a significant increase in mean IC50 values. Remarkably, pretreatment with NTG-NL at both 5 and 100 µg/ml doses exhibit no evidence of NTG tolerance. IC50 are concentrations that produced 50% relaxation in response to NTG stimulation. The maximal relaxation response was, however, similar in the control and both free NTG-treated arteries while the NTG-NL-treated arteries exhibited marginally improved maximal relaxation response. The precise reason for this improvement in maximal relaxation by NTG-NL remains unclear. (D) Demonstration of intracellular NTG-NL uptake and bioavailability following 4h treatment. EC monolayers were treated with L-NIO ± NTG or NTG-NL for 4 hr prior to addition of fluorescently-labeled U937 monocytic cells. Quantification of adherent U937 cells (per mm 2 ) on EC monolayers (n = 10 fields of view) show that both NTG at 5 µM and NTG-NL at 5 µg/ml produce significant inhibition of U937 cell-EC adhesion within 4 hr of treatment. Further, while free NTG loses its therapeutic effect at a 20-fold higher dose of 100 µM, NTG-NL retains its immunosuppressive effects at a similar 20-fold greater dose (100 µg/mL). Thus, the anti-inflammatory effects of free NTG and NTG-NL observed after 4 hr of treatment are consistent with those seen following overnight treatment. **, p<0.01; ***, p<0.001; ns, no significance. Therapeutic dose is highlighted in bold. Data are expressed as mean ± SEM. Table S2 . NL Uptake by Cultured ECs. When added to cultured ECs, fluorescently-labeled nanoliposomes undergo dosedependent uptake by ECs, with the net internalized amount increasing with increasing NL dose. However, this dose-dependent increase in net NL uptake is inversely proportional to percent uptake by ECs, which is the highest at 5 µg/ml dose and decreases progressively with increasing NL dose.
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